DERMA SCIENCES INC's ticker is DSCI and the CUSIP is 249827502. A total of 62 filers reported holding DERMA SCIENCES INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $18,000 | +12.5% | 3,494 | 0.0% | 0.00% | – |
| Q3 2016 | $16,000 | +14.3% | 3,494 | 0.0% | 0.00% | – |
| Q2 2016 | $14,000 | +16.7% | 3,494 | -10.0% | 0.00% | – |
| Q1 2016 | $12,000 | -33.3% | 3,882 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | 0.0% | 3,882 | 0.0% | 0.00% | – |
| Q3 2015 | $18,000 | -33.3% | 3,882 | +4.5% | 0.00% | – |
| Q2 2015 | $27,000 | -95.8% | 3,714 | -95.1% | 0.00% | -100.0% |
| Q1 2015 | $646,000 | -8.2% | 76,216 | +0.8% | 0.00% | 0.0% |
| Q4 2014 | $704,000 | +11.9% | 75,613 | +0.1% | 0.00% | 0.0% |
| Q3 2014 | $629,000 | -26.0% | 75,511 | +2.7% | 0.00% | 0.0% |
| Q2 2014 | $850,000 | -2.0% | 73,523 | +7.5% | 0.00% | 0.0% |
| Q1 2014 | $867,000 | +72.4% | 68,388 | +47.1% | 0.00% | 0.0% |
| Q4 2013 | $503,000 | -14.9% | 46,487 | -2.7% | 0.00% | 0.0% |
| Q3 2013 | $591,000 | -4.7% | 47,768 | +2.9% | 0.00% | 0.0% |
| Q2 2013 | $620,000 | – | 46,422 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 1,994,876 | $24,697,000 | 2.58% |
| Broadfin Capital, LLC | 771,598 | $9,552,000 | 1.70% |
| Raging Capital Management, LLC | 698,401 | $8,646,000 | 1.49% |
| Camber Capital Management LP | 950,000 | $11,761,000 | 1.23% |
| DAFNA Capital Management LLC | 57,009 | $706,000 | 0.77% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 44,027 | $545,000 | 0.67% |
| Baker Brothers Advisors | 2,558,857 | $31,679,000 | 0.45% |
| THB ASSET MANAGEMENT | 430,810 | $5,333,000 | 0.33% |
| EAM Investors, LLC | 100,658 | $1,246,000 | 0.25% |
| ROANOKE ASSET MANAGEMENT CORP/ NY | 32,741 | $390,000 | 0.19% |